Investment analysts at JP Morgan recently raised their rating for Methanex Corporation (MEOH) to “Overweight,” a move that signals a more favorable outlook for the company amidst volatility in its stock price. This upgrade, communicated by Jeffrey Zekauskas on October 31, 2025, comes at a time when MEOH’s stock is currently trading at $39.32, just above its price target of $38. This shift in evaluation reflects confidence in the company’s potential for growth, even as the stock has encountered challenges in the marketplace.
Recent Price Action
Over the last week, MEOH’s stock has experienced a decline, down approximately 4.83% with a price change of -$1.90. Currently trading at $39.32, the stock has encountered significant fluctuations, as evidenced by its week’s high of $54.44 and a low of $27.84 over the past 52 weeks. The volatility can be highlighted by its beta of 1.309, indicating risk levels higher than the broader market. While MEOH recorded 214,354 shares traded in the most recent session, this falls short of its average volume of 482,056, suggesting a cautious approach among investors.
[chart type=’price’ value=’MEOH’]
Short- and Long-Term Performance
Reviewing Methanex’s performance reveals a complex picture. Over the past month, the stock has seen a modest rise of 0.61%, but a more substantial quarterly increase of 18.76% speaks to potential recovery or positive shifts in underlying business conditions. However, on a yearly basis, the stock has faced a slight decline of 1.75%, which presents a mixed performance overall. The 10-day and 3-month average trading volumes reflect heightened trading interest, with 788,859 and 465,859, respectively. Weekly volatility stands at 4.73%, while monthly volatility is lower at 3.86%, indicating that while there may be sharp movements, the stock is relatively stable compared to the wider market fluctuations.
[chart type=’performance’ value=’MEOH’]
Earnings / Financials
Methanex’s latest earnings report, released on October 29, 2025, illustrated a significant disappointment for investors. The company reported an earnings per share (EPS) of $0.06007, which fell short of the consensus estimate of $0.51 by a staggering 88.22%. This marks a notable decrease when compared to the previous quarter, where the actual EPS of $0.97 surpassed the forecast of $0.42, highlighting an inconsistency in performance. The significant negative surprise, coupled with a lack of predictability, raises concerns among investors regarding the company’s operational efficiency and future growth prospects.
[chart type=’income-bar-chart’ value=’MEOH’]
Analyst / Consensus View
The recent upgrade from JP Morgan underlines a budding optimism within the analyst community. The current consensus rating for Methanex remains largely positive, with a solitary “Buy” recommendation from JP Morgan contrasted by no “Hold” or “Sell” ratings. The average, high, and low price targets are all set at $38, aligning with the firm’s strategic outlook. While the single rating leaves room for a wider interpretation of investor sentiment, it suggests that analysts are cautiously optimistic about the company’s long-term prospects, especially considering the recent upgrade.
[chart type=’analyst-ratings’ value=’MEOH’]
Stock Grading or Fundamental View
The Stocks Telegraph grading score for Methanex Corporation stands at 57. This grade indicates a balanced outlook based on the company’s overall health and investment profile, with nuanced strengths and weaknesses. While Methanex is navigating a challenging operating environment and reflecting some uneven performance metrics, the solid score suggests that its fundamentals are strong enough to warrant attention from potential investors.
[chart type=’st-cards’ value=’MEOH’]
Conclusion
For investors, Methanex Corporation represents a compelling opportunity amid the volatility of the chemical manufacturing sector, particularly for those taking a long-term growth perspective. However, it’s essential to weigh the recent earnings disappointment, which may signal operational challenges that could affect future returns. Investors should consider their risk tolerance, as elevated beta values suggest increased volatility compared to the overall market. Keeping a close watch on the company’s strategies in response to these challenges may present valuable insights into its potential upward trajectory. Overall, Methanex merits attention for investors interested in a sector poised for growth, albeit with the understanding of the inherent risks involved.